Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-02 @ 2:39 PM
Study NCT ID:
NCT06318169
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2024-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Sponsor:
89bio, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) … | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Liver Diseases | View |
| None | Fatty Liver | View |
| None | Digestive System Diseases | View |
| None | Metabolic diseases | View |
| None | Metabolic Dysfunction-Associated Steatohepatitis | View |
| None | MASH | View |
| None | Steatohepatitis | View |
| None | Metabolic dysfunction-associated steatotic liver disease | View |
| None | MASLD | View |
| None | Nonalcoholic fatty liver disease | View |
| None | NAFLD | View |
| None | Fibrosis | View |